← Back to Search

Unknown

BMS-986196 and/or Cocktail Probe Substrate Drugs for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by Bristol-Myers Squibb
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 52 days
Awards & highlights

Study Summary

This trial tests how 7 drugs interact with a new medicine in healthy people.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 52 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 52 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Area under the plasma concentration-time curve from time zero extrapolated to infinite time (AUC[INF])
Area under the plasma concentration-time curve from time zero to time of the last quantifiable concentration (AUC[0-T])
Maximum observed plasma concentration (Cmax)
Secondary outcome measures
Apparent terminal phase half-life (T-Half)
Apparent total body clearance (CLT/F)
Intensity of Suicidal Ideation as assessed by the Columbia-Suicide Severity Rating Scale (C-SSRS) Score
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: BMS-986196 and/or Cocktail Probe Substrate DrugsExperimental Treatment8 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BMS-986196
2021
Completed Phase 1
~140
Caffeine
2014
Completed Phase 3
~2980
Montelukast
2008
Completed Phase 4
~15460
Flurbiprofen
2022
Completed Phase 4
~870
Omeprazole
2006
Completed Phase 4
~940
Midazolam
2018
Completed Phase 4
~1910
Digoxin
2017
Completed Phase 4
~670
Pravastatin
2010
Completed Phase 4
~11530

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Bristol-Myers SquibbLead Sponsor
2,638 Previous Clinical Trials
4,128,496 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I potentially qualify for this clinical trial?

"Eligibility for this trial necessitates that participants be in good shape and aged between 18-55. As of now, enrollment is seeking out around 18 qualified subjects."

Answered by AI

What is the approximate size of the cohort participating in this research?

"Indeed, current information on clinicaltrials.gov indicates that this medical trial is presently recruiting participants. The study was first posted on May 31st 2023 and has been updated most recently on July 18th 2023. This research requires the recruitment of 18 individuals from a single site."

Answered by AI

Can the administration of BMS-986196 and/or Cocktail Probe Substrate Drugs be considered safe for humans?

"Limited data on efficacy and safety lead to our team at Power rating BMS-986196 and/or Cocktail Probe Substrate Drugs a 1 out of 3. This is in accordance with its phase 1 classification."

Answered by AI

Are there any openings remaining for those who wish to participate in this experiment?

"Correct. Info from clinicaltrials.gov confirms that this research endeavor, which was first published on May 31st 2023, is still looking for participants. Approximately 18 individuals need to be recruited at one medical facility."

Answered by AI

Does this experiment accept participants aged 80 years and above?

"This clinical trial is looking for volunteers who are between the ages of 18 and 55 years old."

Answered by AI
~10 spots leftby Apr 2025